Abdelmalek, Manal F.
Article History
First Online: 8 January 2021
Competing interests
: Research funding (paid to institution): Allergan, Intercept, Madrigal, Viking, Genfit, Gilead, Galactin, Novo-Nordisk, Novartis, NGM Bio, Bristol-Myers Squibb, Genentech, Celgene, Poxel, Durect, Enyo, Inventiva, Enanta, Target Pharma, Boerhinger-Ingelheim, Hanmi. Advisory/consultancy: Allergan, Intercept, Madrigal, Novo-Nordisk, NGM Bio, Bristol-Myers Squibb, Inventiva, Boerhinger-Ingelheim, Promethera. Speaker’s bureaus: Intercept, Clinical Care Options, Fishawack, Inc, Chronic Liver Disease Foundation, Medscape.
Free to read: This content has been made available to all.